FLUOCINONIDE

FLUOCINONIDE was reported 5704 times

FLUOCINONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POIKILODERMA 5 0.0463
1 SPINAL SYNOVIAL CYST 4 0.0381
2 TINEA VERSICOLOUR 10 0.0278
3 TRANSIENT ACANTHOLYTIC DERMATOSIS 8 0.0272
4 POST INFLAMMATORY PIGMENTATION CHANGE 12 0.0265
5 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 9 0.0251
6 CARDIOACTIVE DRUG LEVEL DECREASED 4 0.0234
7 HAEMANGIOMA OF SKIN 10 0.0229
8 LENTIGO 11 0.0222
9 INTERTRIGO 12 0.0220
10 MITOCHONDRIAL MYOPATHY 4 0.0183
11 SEBORRHOEIC KERATOSIS 26 0.0179
12 NAIL DYSTROPHY 9 0.0161
13 ANDROGENETIC ALOPECIA 4 0.0141
14 BONE METABOLISM DISORDER 4 0.0133
15 DYSHIDROTIC ECZEMA 9 0.0126
16 NON-ALCOHOLIC FATTY LIVER 4 0.0119
17 SEBORRHOEIC DERMATITIS 19 0.0115
18 NITRITE URINE PRESENT 5 0.0114
19 FIBROUS HISTIOCYTOMA 4 0.0114
20 TOPICAL STEROID WITHDRAWAL REACTION 4 0.0103
21 BRONCHITIS ACUTE 4 0.0100
22 MYOFASCIAL PAIN SYNDROME 7 0.0098
23 ALLERGY TO ARTHROPOD STING 4 0.0088
24 BRAIN STEM STROKE 4 0.0081
25 XEROSIS 10 0.0081
26 ORAL LICHEN PLANUS 4 0.0080
27 CHRONIC SPONTANEOUS URTICARIA 9 0.0078
28 GUTTATE PSORIASIS 6 0.0073
29 DACTYLITIS 7 0.0071
30 NEPHROGENIC ANAEMIA 33 0.0071
31 EYE BURNS 4 0.0068
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
33 PAPULE 46 0.0065
34 NAIL PSORIASIS 4 0.0065
35 SKIN PLAQUE 54 0.0064
36 PUSTULE 15 0.0063
37 SKIN DISCOMFORT 17 0.0063
38 HAND DERMATITIS 4 0.0058
39 HYPERPARATHYROIDISM SECONDARY 13 0.0052
40 STEROID WITHDRAWAL SYNDROME 5 0.0049
41 TONGUE ERYTHEMA 4 0.0049
42 MACULE 13 0.0047
43 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 79 0.0046
44 PERIARTHRITIS 10 0.0044
45 REBOUND ACID HYPERSECRETION 13 0.0043
46 PSORIASIS 544 0.0042
47 PYURIA 4 0.0040
48 ALOPECIA AREATA 7 0.0040
49 THERAPEUTIC PRODUCT INEFFECTIVE 15 0.0039
50 DERMATITIS ATOPIC 201 0.0038
51 BONE DEMINERALISATION 4 0.0038
52 TINEA PEDIS 6 0.0038
53 JOINT INSTABILITY 5 0.0036
54 ACTINIC KERATOSIS 9 0.0035
55 DERMATITIS PSORIASIFORM 7 0.0034
56 MELANOCYTIC NAEVUS 15 0.0034
57 NEPHROCALCINOSIS 4 0.0034
58 CONTRAINDICATION TO MEDICAL TREATMENT 5 0.0033
59 BLOOD UREA DECREASED 4 0.0032
60 NEOPLASM SKIN 5 0.0032
61 ONYCHOLYSIS 5 0.0032
62 DIABETIC NEPHROPATHY 7 0.0032
63 HIDRADENITIS 29 0.0032
64 END STAGE RENAL DISEASE 54 0.0030
65 SKIN DEPIGMENTATION 4 0.0029
66 ROSACEA 13 0.0028
67 RENAL TUBULAR ACIDOSIS 6 0.0027
68 PRECANCEROUS SKIN LESION 4 0.0027
69 GENITAL PAIN 4 0.0027
70 EPICONDYLITIS 4 0.0026
71 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
72 PSORIATIC ARTHROPATHY 106 0.0026
73 SKIN FISSURES 51 0.0026
74 POLYCYSTIC OVARIES 4 0.0026
75 SKIN PAPILLOMA 10 0.0025
76 SKIN HYPERTROPHY 7 0.0025
77 SPINAL STENOSIS 10 0.0024
78 EXCORIATION 6 0.0024
79 SKIN LESION 64 0.0023
80 CERVICAL SPINAL STENOSIS 4 0.0023
81 LIPOMA 6 0.0023
82 SKIN HAEMORRHAGE 34 0.0023
83 ROTATOR CUFF REPAIR 4 0.0023
84 INFUSION SITE DISCHARGE 4 0.0023
85 KYPHOSIS 4 0.0023
86 DANDRUFF 5 0.0023
87 ECZEMA 118 0.0023
88 PRE-EXISTING CONDITION IMPROVED 14 0.0022
89 SKIN WEEPING 8 0.0022
90 ESSENTIAL HYPERTENSION 4 0.0022
91 HAEMANGIOMA 5 0.0022
92 LICHEN PLANUS 5 0.0022
93 ANTINUCLEAR ANTIBODY POSITIVE 7 0.0022
94 NEURODERMATITIS 8 0.0021
95 CHRONIC KIDNEY DISEASE 160 0.0021
96 IMPAIRED QUALITY OF LIFE 30 0.0021
97 HORDEOLUM 9 0.0021
98 EYELID MARGIN CRUSTING 6 0.0021
99 DERMATITIS 43 0.0021
100 SKIN EXFOLIATION 173 0.0020
101 NASAL SEPTUM DEVIATION 4 0.0020
102 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
103 BLEPHARITIS 8 0.0020
104 REBOUND ATOPIC DERMATITIS 4 0.0020
105 EYELID PAIN 4 0.0020
106 SCLERODERMA 7 0.0019
107 HYPERLIPIDAEMIA 23 0.0019
108 SKIN ATROPHY 11 0.0019
109 DEVICE CONNECTION ISSUE 4 0.0019
110 TORTICOLLIS 4 0.0019
111 DISCOMFORT 115 0.0019
112 INFUSION SITE BRUISING 4 0.0019
113 GAMBLING DISORDER 5 0.0018
114 PARANASAL SINUS DISCOMFORT 7 0.0018
115 DERMATITIS CONTACT 21 0.0018
116 TENDERNESS 19 0.0018
117 THERAPEUTIC AGENT TOXICITY 6 0.0018
118 RHINITIS ALLERGIC 8 0.0018
119 GASTRIC POLYPS 4 0.0018
120 PUSTULAR PSORIASIS 6 0.0017
121 BLOOD CHOLESTEROL ABNORMAL 8 0.0017
122 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
123 MATERNAL EXPOSURE DURING BREAST FEEDING 7 0.0017
124 ECONOMIC PROBLEM 26 0.0017
125 SCRATCH 18 0.0017
126 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 4 0.0017
127 SCAB 19 0.0017
128 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 118 0.0017
129 TONGUE DISCOMFORT 7 0.0016
130 DENTAL OPERATION 4 0.0016
131 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
132 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
133 EYELIDS PRURITUS 5 0.0016
134 ONYCHOMYCOSIS 7 0.0016
135 WHEELCHAIR USER 7 0.0016
136 PARANASAL SINUS HYPERSECRETION 6 0.0016
137 ORTHOPNOEA 5 0.0016
138 PLANTAR FASCIITIS 5 0.0015
139 FUNGAL SKIN INFECTION 6 0.0015
140 SKIN ABRASION 7 0.0015
141 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
142 SPINAL OSTEOARTHRITIS 13 0.0015
143 DERMATITIS ACNEIFORM 9 0.0015
144 TOOTH ABSCESS 15 0.0015
145 SKIN WRINKLING 4 0.0015
146 PERIPHERAL VENOUS DISEASE 6 0.0015
147 HYPERKERATOSIS 8 0.0014
148 TREATMENT FAILURE 119 0.0014
149 ORAL HERPES 28 0.0014
150 TRICHORRHEXIS 4 0.0014
151 FOOT OPERATION 7 0.0014
152 SEASONAL ALLERGY 20 0.0014
153 AORTIC VALVE INCOMPETENCE 6 0.0014
154 SKIN SWELLING 12 0.0014
155 ANHEDONIA 36 0.0014
156 LUMBAR SPINAL STENOSIS 4 0.0014
157 BASAL CELL CARCINOMA 21 0.0013
158 COLITIS ISCHAEMIC 9 0.0013
159 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
160 SLEEP DISORDER 93 0.0013
161 NODULE 17 0.0013
162 OESOPHAGEAL DISORDER 5 0.0013
163 ERYTHEMA OF EYELID 7 0.0013
164 FAMILY STRESS 4 0.0013
165 EPIGASTRIC DISCOMFORT 5 0.0013
166 SKIN HYPERPIGMENTATION 11 0.0013
167 MULTIPLE INJURIES 8 0.0013
168 NON-CARDIAC CHEST PAIN 4 0.0013
169 SKIN DISORDER 42 0.0013
170 DERMATITIS BULLOUS 9 0.0012
171 POSTURE ABNORMAL 4 0.0012
172 SCAR 21 0.0012
173 DRY EYE 61 0.0012
174 INFUSION SITE HAEMORRHAGE 4 0.0012
175 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
176 DIABETIC NEUROPATHY 6 0.0012
177 SLEEP APNOEA SYNDROME 23 0.0012
178 SKIN WARM 7 0.0012
179 SKIN MASS 8 0.0012
180 PEMPHIGOID 9 0.0012
181 APPLICATION SITE DRYNESS 4 0.0012
182 GOUT 21 0.0012
183 SHOULDER OPERATION 5 0.0012
184 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
185 ECCHYMOSIS 8 0.0012
186 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
187 ADRENAL INSUFFICIENCY 14 0.0012
188 PRURITUS 443 0.0012
189 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
190 RASH PRURITIC 62 0.0011
191 EAR PRURITUS 4 0.0011
192 GRIP STRENGTH DECREASED 10 0.0011
193 CONJUNCTIVITIS 21 0.0011
194 OBESITY 18 0.0011
195 ATRIAL FLUTTER 9 0.0011
196 PRODUCT RESIDUE PRESENT 6 0.0011
197 LIGAMENT SPRAIN 11 0.0011
198 EYE PRURITUS 37 0.0011
199 SPONDYLITIS 4 0.0011
200 ABDOMINAL HERNIA 5 0.0011
201 RASH ERYTHEMATOUS 52 0.0011
202 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
203 DRY SKIN 144 0.0011
204 SKIN TIGHTNESS 5 0.0011
205 REBOUND EFFECT 12 0.0011
206 RASH 462 0.0011
207 PRODUCT DOSE OMISSION IN ERROR 30 0.0011
208 CHOLECYSTITIS CHRONIC 7 0.0010
209 SUBCUTANEOUS ABSCESS 5 0.0010
210 GINGIVAL DISORDER 4 0.0010
211 RENAL FAILURE CHRONIC 8 0.0010
212 DERMATITIS ALLERGIC 13 0.0010
213 REHABILITATION THERAPY 4 0.0010
214 HYPERTRIGLYCERIDAEMIA 6 0.0010
215 PROSTATOMEGALY 4 0.0010
216 ONYCHOCLASIS 7 0.0010
217 ROTATOR CUFF SYNDROME 13 0.0010
218 CARDIAC PACEMAKER INSERTION 6 0.0010
219 RASH MACULAR 35 0.0010
220 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
221 MUSCULOSKELETAL DISCOMFORT 17 0.0010
222 VULVOVAGINAL PRURITUS 5 0.0010
223 DIVERTICULUM 7 0.0010
224 TRIGGER FINGER 4 0.0010
225 NERVE COMPRESSION 9 0.0010
226 PIGMENTATION DISORDER 6 0.0010
227 PRODUCT DISTRIBUTION ISSUE 9 0.0010
228 STAPHYLOCOCCAL INFECTION 32 0.0010
229 ARTHRITIS 76 0.0010
230 NEPHROPATHY 9 0.0010
231 CHOLECYSTECTOMY 11 0.0010
232 THERAPY PARTIAL RESPONDER 15 0.0010
233 WEIGHT FLUCTUATION 10 0.0010
234 FOLLICULITIS 10 0.0010
235 ARTHROPOD BITE 7 0.0009
236 BUNDLE BRANCH BLOCK LEFT 4 0.0009
237 POOR PERIPHERAL CIRCULATION 4 0.0009
238 ABSCESS LIMB 4 0.0009
239 MUSCLE STRAIN 8 0.0009
240 BODY TEMPERATURE DECREASED 9 0.0009
241 PRODUCT USE IN UNAPPROVED INDICATION 226 0.0009
242 TOOTH INFECTION 12 0.0009
243 PARONYCHIA 4 0.0009
244 SINUS DISORDER 18 0.0009
245 ABDOMINAL ABSCESS 4 0.0009
246 MULTIPLE ALLERGIES 7 0.0009
247 RASH PAPULAR 20 0.0009
248 FISTULA 10 0.0009
249 TRICUSPID VALVE INCOMPETENCE 7 0.0009
250 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
251 IMPAIRED GASTRIC EMPTYING 12 0.0009
252 EXOSTOSIS 8 0.0009
253 CARDIAC VALVE DISEASE 5 0.0009
254 EAR DISORDER 4 0.0009
255 RENAL FAILURE 116 0.0009
256 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
257 DYSPAREUNIA 4 0.0009
258 SKIN DISCOLOURATION 40 0.0009
259 HERPES VIRUS INFECTION 5 0.0009
260 EYE OPERATION 4 0.0009
261 LARGE INTESTINE POLYP 6 0.0009
262 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
263 POST PROCEDURAL INFECTION 7 0.0009
264 FEELING OF DESPAIR 4 0.0009
265 CARPAL TUNNEL SYNDROME 12 0.0009
266 ERYTHEMA 175 0.0009
267 ORAL PAIN 19 0.0008
268 THERAPY NON-RESPONDER 38 0.0008
269 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
270 THERAPEUTIC RESPONSE SHORTENED 28 0.0008
271 SINUS HEADACHE 5 0.0008
272 APHAGIA 4 0.0008
273 HUMERUS FRACTURE 4 0.0008
274 HYPERCHOLESTEROLAEMIA 8 0.0008
275 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
276 EYE IRRITATION 47 0.0008
277 SCIATICA 13 0.0008
278 BLOOD CHOLESTEROL INCREASED 38 0.0008
279 SENSITIVE SKIN 6 0.0008
280 MENISCUS INJURY 5 0.0008
281 SPRUE-LIKE ENTEROPATHY 4 0.0008
282 NERVE INJURY 9 0.0008
283 HYPERVOLAEMIA 4 0.0008
284 OCULAR HYPERAEMIA 38 0.0008
285 NAIL DISORDER 7 0.0008
286 NASAL DRYNESS 5 0.0008
287 PRODUCT DOSE OMISSION 52 0.0008
288 SWELLING OF EYELID 5 0.0008
289 BOWEL MOVEMENT IRREGULARITY 6 0.0008
290 GASTROINTESTINAL INFECTION 7 0.0008
291 PAIN OF SKIN 21 0.0008
292 TEMPERATURE INTOLERANCE 8 0.0008
293 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
294 CONCUSSION 6 0.0008
295 FAILURE TO THRIVE 4 0.0008
296 SKIN IRRITATION 35 0.0008
297 CORONARY ARTERY DISEASE 23 0.0008
298 WALKING AID USER 5 0.0008
299 JOINT DISLOCATION 8 0.0008
300 BLOOD PRESSURE ABNORMAL 15 0.0008
301 CELLULITIS 38 0.0008
302 GINGIVAL PAIN 6 0.0008
303 FOOD POISONING 4 0.0007
304 ACUTE KIDNEY INJURY 114 0.0007
305 OVERWEIGHT 4 0.0007
306 SKIN CANCER 16 0.0007
307 DECUBITUS ULCER 6 0.0007
308 NORMAL NEWBORN 4 0.0007
309 OSTEOARTHRITIS 31 0.0007
310 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
311 ASTHENOPIA 4 0.0007
312 PHOTOSENSITIVITY REACTION 12 0.0007
313 APPLICATION SITE PAIN 16 0.0007
314 CHOKING SENSATION 4 0.0007
315 OSTEOPENIA 11 0.0007
316 LYMPHOEDEMA 5 0.0007
317 DIZZINESS POSTURAL 7 0.0007
318 AUTOIMMUNE HEPATITIS 5 0.0007
319 VITAMIN D DEFICIENCY 7 0.0007
320 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
321 THYROID DISORDER 11 0.0007
322 SKIN INFECTION 8 0.0007
323 PRODUCT LEAKAGE 4 0.0007
324 BLISTER 40 0.0007
325 PRODUCTIVE COUGH 34 0.0007
326 CANDIDA INFECTION 12 0.0007
327 THERAPEUTIC RESPONSE DECREASED 43 0.0007
328 IRRITABLE BOWEL SYNDROME 15 0.0007
329 CARDIAC OPERATION 6 0.0007
330 GRAFT VERSUS HOST DISEASE 5 0.0007
331 BLOOD MAGNESIUM DECREASED 6 0.0007
332 PSYCHOLOGICAL TRAUMA 6 0.0007
333 MOUTH SWELLING 4 0.0007
334 SINUSITIS 71 0.0007
335 PHOTOPHOBIA 13 0.0007
336 RALES 4 0.0007
337 RASH PUSTULAR 5 0.0007
338 SURGERY 40 0.0007
339 ORAL DISORDER 5 0.0007
340 EAR DISCOMFORT 7 0.0007
341 LIMB DISCOMFORT 21 0.0007
342 BACK DISORDER 11 0.0007
343 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
344 BACTERAEMIA 8 0.0007
345 RENAL INJURY 20 0.0007
346 PULMONARY MASS 10 0.0007
347 QUALITY OF LIFE DECREASED 9 0.0007
348 INTENTIONAL DOSE OMISSION 19 0.0007
349 KNEE ARTHROPLASTY 14 0.0007
350 APPLICATION SITE PRURITUS 15 0.0007
351 RESPIRATORY TRACT INFECTION 17 0.0007
352 RETINAL DETACHMENT 6 0.0007
353 INCREASED TENDENCY TO BRUISE 6 0.0007
354 PRODUCT DOSE OMISSION ISSUE 191 0.0006
355 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
356 CYST 8 0.0006
357 SKIN LACERATION 7 0.0006
358 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
359 SECRETION DISCHARGE 8 0.0006
360 SQUAMOUS CELL CARCINOMA 6 0.0006
361 AFFECTIVE DISORDER 5 0.0006
362 INFUSION SITE SWELLING 4 0.0006
363 TOOTH FRACTURE 7 0.0006
364 BRONCHITIS 47 0.0006
365 FOOT FRACTURE 12 0.0006
366 FOOT DEFORMITY 7 0.0006
367 THERAPEUTIC RESPONSE CHANGED 4 0.0006
368 FURUNCLE 5 0.0006
369 BLOOD ALBUMIN DECREASED 5 0.0006
370 ARTHROPATHY 35 0.0006
371 RENAL CYST 5 0.0006
372 RESPIRATORY TRACT CONGESTION 10 0.0006
373 LACRIMATION INCREASED 19 0.0006
374 SKIN BURNING SENSATION 45 0.0006
375 POST PROCEDURAL COMPLICATION 12 0.0006
376 ILLNESS 64 0.0006
377 SENSORY LOSS 5 0.0006
378 EYE PAIN 35 0.0006
379 EYE INFECTION 7 0.0006
380 MITRAL VALVE INCOMPETENCE 7 0.0006
381 APPLICATION SITE VESICLES 4 0.0006
382 IMPAIRED DRIVING ABILITY 7 0.0006
383 AUTOIMMUNE DISORDER 6 0.0006
384 ABNORMAL FAECES 5 0.0006
385 JOINT STIFFNESS 16 0.0006
386 NEOPLASM 7 0.0006
387 NECK PAIN 34 0.0006
388 ORAL CANDIDIASIS 8 0.0006
389 SPINAL COMPRESSION FRACTURE 5 0.0006
390 APPETITE DISORDER 4 0.0006
391 EMBOLISM 5 0.0006
392 SALIVARY HYPERSECRETION 6 0.0006
393 HAIR TEXTURE ABNORMAL 8 0.0006
394 INJECTION SITE REACTION 41 0.0006
395 METASTASES TO LYMPH NODES 4 0.0006
396 DRUG INEFFECTIVE 780 0.0006
397 HEPATIC STEATOSIS 11 0.0006
398 DRY THROAT 6 0.0006
399 INSURANCE ISSUE 9 0.0006
400 RHINORRHOEA 38 0.0006
401 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
402 VITAMIN D DECREASED 5 0.0006
403 DYSPNOEA EXERTIONAL 22 0.0006
404 NEPHROTIC SYNDROME 4 0.0006
405 RIB FRACTURE 12 0.0006
406 ANKLE FRACTURE 9 0.0006
407 DROOLING 4 0.0006
408 EXPOSURE VIA SKIN CONTACT 15 0.0006
409 HAIR GROWTH ABNORMAL 4 0.0006
410 EYE DISCHARGE 6 0.0006
411 FIBROMYALGIA 14 0.0006
412 NEURALGIA 14 0.0006
413 APPLICATION SITE ERYTHEMA 15 0.0006
414 URINE OUTPUT DECREASED 5 0.0006
415 MOUTH ULCERATION 12 0.0006
416 SMALL INTESTINAL OBSTRUCTION 7 0.0006
417 SKIN REACTION 8 0.0006
418 INJECTION SITE EXTRAVASATION 7 0.0006
419 LUNG INFILTRATION 5 0.0006
420 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
421 ULCER 9 0.0006
422 PULMONARY TOXICITY 4 0.0006
423 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
424 PHARYNGITIS 7 0.0006
425 HAEMORRHOIDS 11 0.0006
426 FEAR OF INJECTION 4 0.0006
427 ALOPECIA 110 0.0006
428 OSTEOPOROSIS 23 0.0006
429 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
430 CONDITION AGGRAVATED 169 0.0006
431 HAEMATOCRIT DECREASED 11 0.0006
432 TONGUE DISORDER 4 0.0006
433 TOOTHACHE 10 0.0006
434 BIPOLAR DISORDER 6 0.0006
435 OESOPHAGITIS 6 0.0005
436 SPINAL FRACTURE 11 0.0005
437 CHOLELITHIASIS 18 0.0005
438 BONE DISORDER 10 0.0005
439 NASAL CONGESTION 32 0.0005
440 BONE DENSITY DECREASED 17 0.0005
441 TASTE DISORDER 11 0.0005
442 SKIN ULCER 14 0.0005
443 RASH GENERALISED 14 0.0005
444 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
445 LOCALISED INFECTION 13 0.0005
446 SUNBURN 4 0.0005
447 BLOOD CALCIUM DECREASED 6 0.0005
448 BEDRIDDEN 7 0.0005
449 ARTERIOSCLEROSIS 5 0.0005
450 INTESTINAL OBSTRUCTION 20 0.0005
451 TOOTH LOSS 11 0.0005
452 PULMONARY HYPERTENSION 11 0.0005
453 MYOCARDIAL ISCHAEMIA 6 0.0005
454 AORTIC ANEURYSM 4 0.0005
455 MUSCULOSKELETAL DISORDER 10 0.0005
456 EYE INFLAMMATION 5 0.0005
457 MIGRAINE 50 0.0005
458 ACIDOSIS 4 0.0005
459 MALIGNANT MELANOMA 7 0.0005
460 CATARACT 31 0.0005
461 METASTASES TO LUNG 6 0.0005
462 OROPHARYNGEAL PAIN 48 0.0005
463 FOOD ALLERGY 4 0.0005
464 SINUS BRADYCARDIA 5 0.0005
465 MUSCULOSKELETAL CHEST PAIN 8 0.0005
466 TENDONITIS 8 0.0005
467 ASTHMA 58 0.0005
468 LIVER FUNCTION TEST INCREASED 11 0.0005
469 ARTHRALGIA 213 0.0005
470 INFECTION 74 0.0005
471 EYE SWELLING 19 0.0005
472 BRAIN FOG 8 0.0005
473 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
474 RENAL TUBULAR NECROSIS 5 0.0005
475 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
476 COVID-19 PNEUMONIA 6 0.0005
477 DISABILITY 10 0.0005
478 DIVERTICULITIS 14 0.0005
479 HYPERTENSION 107 0.0005
480 PRODUCT PRESCRIBING ERROR 12 0.0005
481 COORDINATION ABNORMAL 7 0.0005
482 ABDOMINAL DISCOMFORT 84 0.0005
483 PERIPHERAL SWELLING 77 0.0005
484 NASOPHARYNGITIS 92 0.0005
485 OSTEOMYELITIS 9 0.0005
486 DEPRESSION 113 0.0005
487 STENT PLACEMENT 4 0.0005
488 EMPHYSEMA 5 0.0005
489 RESTLESS LEGS SYNDROME 9 0.0005
490 BURSITIS 6 0.0005
491 VAGINAL DISCHARGE 5 0.0005
492 URINARY TRACT INFECTION 84 0.0005
493 FLUID RETENTION 25 0.0005
494 DRUG LEVEL DECREASED 5 0.0005
495 RECTAL HAEMORRHAGE 21 0.0005
496 CONTUSION 47 0.0005
497 CARDIOMEGALY 6 0.0005
498 INITIAL INSOMNIA 5 0.0005
499 SPINAL OPERATION 6 0.0005
500 INFLAMMATION 25 0.0005
501 HEART RATE DECREASED 17 0.0005
502 URTICARIA 81 0.0005
503 POOR VENOUS ACCESS 5 0.0005
504 ILEUS 6 0.0005
505 JOINT SWELLING 58 0.0005
506 FUNGAL INFECTION 16 0.0005
507 PETECHIAE 5 0.0005
508 ADVERSE DRUG REACTION 43 0.0005
509 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 86 0.0005
510 INFUSION SITE ERYTHEMA 4 0.0005
511 BALANCE DISORDER 41 0.0005
512 INJECTION SITE IRRITATION 6 0.0005
513 BURNING SENSATION 33 0.0005
514 INJECTION SITE SWELLING 36 0.0005
515 IMMUNODEFICIENCY 7 0.0005
516 HYPOPHAGIA 12 0.0005
517 GASTROINTESTINAL DISORDER 42 0.0005
518 PROCEDURAL PAIN 13 0.0005
519 JOINT INJURY 10 0.0005
520 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
521 ANXIETY 133 0.0005
522 PRODUCT CONTAINER ISSUE 4 0.0005
523 HAEMOPTYSIS 13 0.0005
524 BONE LOSS 7 0.0005
525 BLOOD POTASSIUM DECREASED 14 0.0005
526 DECREASED ACTIVITY 5 0.0005
527 CARDIAC MURMUR 4 0.0005
528 PHARYNGITIS STREPTOCOCCAL 5 0.0005
529 HYSTERECTOMY 4 0.0005
530 ORTHOSTATIC HYPOTENSION 8 0.0005
531 DEAFNESS 12 0.0005
532 PAIN IN JAW 13 0.0005
533 TINNITUS 21 0.0005
534 IMPAIRED HEALING 15 0.0005
535 WOUND INFECTION 5 0.0005
536 EYE DISORDER 15 0.0005
537 COVID-19 80 0.0005
538 ANKYLOSING SPONDYLITIS 6 0.0005
539 PULMONARY CONGESTION 6 0.0005
540 LYMPHOMA 7 0.0005
541 COUGH 127 0.0005
542 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
543 WITHDRAWAL SYNDROME 19 0.0005
544 PRESYNCOPE 11 0.0005
545 EAR INFECTION 12 0.0005
546 PAIN 277 0.0005
547 STEVENS-JOHNSON SYNDROME 10 0.0004
548 RASH MACULO-PAPULAR 10 0.0004
549 MUSCULAR WEAKNESS 51 0.0004
550 INJECTION SITE URTICARIA 11 0.0004
551 FACIAL PAIN 4 0.0004
552 DIARRHOEA 289 0.0004
553 BACK PAIN 104 0.0004
554 DRUG EFFECT DECREASED 24 0.0004
555 DYSSTASIA 13 0.0004
556 ANAL INCONTINENCE 4 0.0004
557 GASTROENTERITIS VIRAL 8 0.0004
558 OROPHARYNGEAL DISCOMFORT 4 0.0004
559 CYSTITIS 14 0.0004
560 TREATMENT NONCOMPLIANCE 24 0.0004
561 CORONARY ARTERY OCCLUSION 6 0.0004
562 PERIPHERAL COLDNESS 6 0.0004
563 APPLICATION SITE RASH 6 0.0004
564 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
565 HERPES ZOSTER 25 0.0004
566 RESPIRATORY DISORDER 13 0.0004
567 MUSCULOSKELETAL STIFFNESS 38 0.0004
568 PERICARDIAL EFFUSION 10 0.0004
569 BLOOD POTASSIUM INCREASED 7 0.0004
570 HUNGER 6 0.0004
571 WOUND 12 0.0004
572 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
573 GAIT DISTURBANCE 82 0.0004
574 COGNITIVE DISORDER 20 0.0004
575 PAIN IN EXTREMITY 126 0.0004
576 SWELLING 40 0.0004
577 PNEUMONIA 138 0.0004
578 HEADACHE 267 0.0004
579 OEDEMA 23 0.0004
580 INJECTION SITE RASH 13 0.0004
581 UNEVALUABLE EVENT 32 0.0004
582 EATING DISORDER 9 0.0004
583 FRACTURE 8 0.0004
584 SINUS TACHYCARDIA 6 0.0004
585 ACNE 32 0.0004
586 SPUTUM DISCOLOURED 4 0.0004
587 BLOOD IRON DECREASED 5 0.0004
588 RED BLOOD CELL COUNT DECREASED 12 0.0004
589 GASTRITIS 11 0.0004
590 ACUTE RESPIRATORY FAILURE 8 0.0004
591 EMOTIONAL DISTRESS 50 0.0004
592 INJURY 29 0.0004
593 FLUID OVERLOAD 6 0.0004
594 NOCTURIA 5 0.0004
595 HYPOKALAEMIA 19 0.0004
596 EAR PAIN 8 0.0004
597 DYSPHONIA 24 0.0004
598 OEDEMA PERIPHERAL 50 0.0004
599 INSOMNIA 109 0.0004
600 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
601 COELIAC DISEASE 4 0.0004
602 POLLAKIURIA 17 0.0004
603 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
604 URINARY INCONTINENCE 12 0.0004
605 HOSPICE CARE 4 0.0004
606 TOOTH DISORDER 9 0.0004
607 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
608 CONSTIPATION 88 0.0004
609 NIGHT SWEATS 13 0.0004
610 APPLICATION SITE IRRITATION 5 0.0004
611 HAIR COLOUR CHANGES 5 0.0004
612 TOOTH EXTRACTION 5 0.0004
613 LOCAL SWELLING 7 0.0004
614 INJECTION SITE DISCOLOURATION 5 0.0004
615 BLOOD PRESSURE INCREASED 61 0.0004
616 HYPOXIA 14 0.0004
617 PRODUCT ADMINISTRATION ERROR 8 0.0004
618 DRUG ERUPTION 7 0.0004
619 EXTRA DOSE ADMINISTERED 16 0.0004
620 MUSCLE ATROPHY 5 0.0004
621 DRY MOUTH 32 0.0004
622 EYELID PTOSIS 4 0.0004
623 HYPERSENSITIVITY 73 0.0004
624 SLUGGISHNESS 4 0.0004
625 MOBILITY DECREASED 28 0.0004
626 THERAPY CESSATION 20 0.0004
627 PRODUCT USE ISSUE 73 0.0004
628 FALL 129 0.0004
629 VISION BLURRED 53 0.0004
630 SWELLING FACE 25 0.0004
631 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
632 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
633 INJECTION SITE DISCOMFORT 4 0.0004
634 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4 0.0004
635 NEUROPATHY PERIPHERAL 36 0.0004
636 ACCIDENTAL EXPOSURE TO PRODUCT 39 0.0004
637 INCONTINENCE 4 0.0004
638 CHEST PAIN 70 0.0004
639 THERAPY INTERRUPTED 27 0.0004
640 ADVERSE REACTION 5 0.0004
641 FATIGUE 293 0.0004
642 EPISTAXIS 28 0.0004
643 BODY HEIGHT DECREASED 4 0.0004
644 OXYGEN SATURATION DECREASED 21 0.0004
645 JOINT RANGE OF MOTION DECREASED 5 0.0004
646 LABORATORY TEST ABNORMAL 11 0.0004
647 MUSCLE TIGHTNESS 6 0.0004
648 RENAL IMPAIRMENT 31 0.0004
649 UVEITIS 5 0.0004
650 LIMB INJURY 10 0.0004
651 BACK INJURY 4 0.0004
652 DEHYDRATION 49 0.0004
653 PRODUCT PRESCRIBING ISSUE 8 0.0004
654 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
655 GINGIVAL BLEEDING 5 0.0004
656 PULMONARY FIBROSIS 7 0.0004
657 GLAUCOMA 7 0.0004
658 INJECTION SITE NODULE 4 0.0004
659 RESPIRATORY DISTRESS 10 0.0004
660 HERNIA 7 0.0004
661 WEIGHT DECREASED 101 0.0004
662 ERUCTATION 7 0.0004
663 DENTAL CARIES 4 0.0004
664 VIRAL INFECTION 12 0.0004
665 MENTAL STATUS CHANGES 10 0.0004
666 FEELING COLD 10 0.0004
667 FEELING HOT 22 0.0004
668 PALPITATIONS 42 0.0004
669 KIDNEY INFECTION 7 0.0004
670 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
671 ABDOMINAL PAIN LOWER 9 0.0004
672 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
673 BLINDNESS UNILATERAL 5 0.0004
674 WHEEZING 21 0.0004
675 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
676 PRODUCT AVAILABILITY ISSUE 8 0.0004
677 NAUSEA 278 0.0004
678 MICTURITION URGENCY 4 0.0003
679 INTERNAL HAEMORRHAGE 4 0.0003
680 SEPSIS 39 0.0003
681 ANGINA PECTORIS 10 0.0003
682 HYPERSOMNIA 10 0.0003
683 PULMONARY EMBOLISM 33 0.0003
684 PRODUCT PHYSICAL ISSUE 7 0.0003
685 DIZZINESS 173 0.0003
686 DIPLOPIA 9 0.0003
687 DEVICE DEFECTIVE 6 0.0003
688 ILL-DEFINED DISORDER 21 0.0003
689 DYSPEPSIA 34 0.0003
690 INJECTION SITE PAIN 106 0.0003
691 HOT FLUSH 26 0.0003
692 HYPOTHYROIDISM 11 0.0003
693 RENAL DISORDER 16 0.0003
694 COLITIS 13 0.0003
695 APATHY 5 0.0003
696 GASTROENTERITIS 5 0.0003
697 MEMORY IMPAIRMENT 47 0.0003
698 CHEST DISCOMFORT 35 0.0003
699 INFLUENZA 38 0.0003
700 COLD SWEAT 6 0.0003
701 LYMPHADENOPATHY 12 0.0003
702 DEEP VEIN THROMBOSIS 22 0.0003
703 CHOLECYSTITIS 4 0.0003
704 ANAEMIA 64 0.0003
705 PULMONARY OEDEMA 15 0.0003
706 MACULAR DEGENERATION 4 0.0003
707 HYPOAESTHESIA 50 0.0003
708 ASTHENIA 125 0.0003
709 CARDIAC DISORDER 31 0.0003
710 HEPATITIS C 4 0.0003
711 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
712 PELVIC PAIN 6 0.0003
713 CRYING 12 0.0003
714 INJECTION SITE PRURITUS 22 0.0003
715 RETCHING 7 0.0003
716 DIABETES MELLITUS 25 0.0003
717 TYPE 2 DIABETES MELLITUS 11 0.0003
718 DYSURIA 12 0.0003
719 ABDOMINAL PAIN UPPER 67 0.0003
720 HYPOACUSIS 14 0.0003
721 DEVICE RELATED INFECTION 5 0.0003
722 PARAESTHESIA 51 0.0003
723 TENDON RUPTURE 4 0.0003
724 CARDIAC FAILURE CONGESTIVE 26 0.0003
725 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
726 EJECTION FRACTION DECREASED 5 0.0003
727 MUSCLE SPASMS 59 0.0003
728 SWOLLEN TONGUE 10 0.0003
729 DYSPNOEA 181 0.0003
730 ATRIAL FIBRILLATION 31 0.0003
731 BLOOD SODIUM DECREASED 6 0.0003
732 FLATULENCE 18 0.0003
733 HEAD INJURY 10 0.0003
734 GASTRIC ULCER 6 0.0003
735 PROTEINURIA 6 0.0003
736 TRANSAMINASES INCREASED 7 0.0003
737 ABDOMINAL PAIN 73 0.0003
738 ABSCESS 5 0.0003
739 INTRAOCULAR PRESSURE INCREASED 4 0.0003
740 OFF LABEL USE 274 0.0003
741 MYALGIA 53 0.0003
742 HAEMOGLOBIN DECREASED 32 0.0003
743 ERECTILE DYSFUNCTION 8 0.0003
744 ROAD TRAFFIC ACCIDENT 13 0.0003
745 INFUSION SITE PAIN 4 0.0003
746 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
747 HEART RATE IRREGULAR 7 0.0003
748 HIATUS HERNIA 4 0.0003
749 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
750 CHOKING 6 0.0003
751 AMNESIA 20 0.0003
752 CHILLS 36 0.0003
753 PLATELET COUNT INCREASED 4 0.0003
754 VISUAL IMPAIRMENT 38 0.0003
755 HAEMORRHAGE 32 0.0003
756 MULTIPLE FRACTURES 5 0.0003
757 MANIA 5 0.0003
758 MUSCLE TWITCHING 7 0.0003
759 IMMUNE SYSTEM DISORDER 4 0.0003
760 DEPRESSED MOOD 16 0.0003
761 COAGULOPATHY 5 0.0003
762 EYE HAEMORRHAGE 4 0.0003
763 BLOOD UREA INCREASED 5 0.0003
764 FEAR 8 0.0003
765 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
766 FREQUENT BOWEL MOVEMENTS 8 0.0003
767 SINUS CONGESTION 4 0.0003
768 MOOD ALTERED 8 0.0003
769 FEELING ABNORMAL 70 0.0003
770 HAEMATURIA 10 0.0003
771 HYPOTENSION 58 0.0003
772 ORAL DISCOMFORT 4 0.0003
773 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
774 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
775 SPEECH DISORDER 15 0.0003
776 DEMENTIA 8 0.0003
777 MASS 4 0.0003
778 DEVICE USE ISSUE 5 0.0003
779 WEIGHT INCREASED 64 0.0003
780 INTENTIONAL PRODUCT MISUSE 25 0.0003
781 DEVICE OCCLUSION 4 0.0003
782 LYMPHOPENIA 4 0.0003
783 HEAD DISCOMFORT 5 0.0003
784 AGEUSIA 7 0.0003
785 GALLBLADDER DISORDER 5 0.0003
786 SYNCOPE 28 0.0003
787 PLEURAL EFFUSION 17 0.0003
788 VERTIGO 17 0.0003
789 HEPATIC ENZYME INCREASED 19 0.0003
790 ABDOMINAL DISTENSION 29 0.0003
791 ANOSMIA 4 0.0003
792 LEUKOCYTOSIS 5 0.0003
793 MENTAL DISORDER 12 0.0003
794 PANIC ATTACK 10 0.0003
795 RESPIRATORY FAILURE 20 0.0003
796 DYSPHAGIA 26 0.0003
797 RESTLESSNESS 10 0.0003
798 BONE PAIN 16 0.0003
799 HAEMATOCHEZIA 15 0.0003
800 ACUTE MYOCARDIAL INFARCTION 8 0.0003
801 MIDDLE INSOMNIA 5 0.0003
802 PYREXIA 92 0.0003
803 LUNG DISORDER 13 0.0003
804 HYPERHIDROSIS 34 0.0003
805 BLOOD COUNT ABNORMAL 4 0.0003
806 GASTRIC DISORDER 9 0.0003
807 VOMITING 123 0.0003
808 LOWER LIMB FRACTURE 5 0.0003
809 DRUG PRESCRIBING ERROR 5 0.0003
810 LUNG INFECTION 4 0.0003
811 PNEUMONITIS 7 0.0003
812 BLOOD PRESSURE DECREASED 17 0.0003
813 FLUSHING 26 0.0003
814 BLOOD GLUCOSE INCREASED 48 0.0003
815 DECREASED APPETITE 59 0.0003
816 PRODUCT USE COMPLAINT 4 0.0003
817 PLATELET COUNT DECREASED 27 0.0003
818 SOMNOLENCE 51 0.0003
819 MALAISE 111 0.0003
820 THROMBOCYTOPENIA 28 0.0003
821 MENTAL IMPAIRMENT 6 0.0002
822 STOMATITIS 15 0.0002
823 RHEUMATOID ARTHRITIS 28 0.0002
824 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
825 INJECTION SITE MASS 9 0.0002
826 INJECTION SITE WARMTH 5 0.0002
827 INFLUENZA LIKE ILLNESS 20 0.0002
828 INJECTION SITE ERYTHEMA 30 0.0002
829 MYOCARDIAL INFARCTION 42 0.0002
830 LIP SWELLING 8 0.0002
831 NEPHROLITHIASIS 11 0.0002
832 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
833 HALLUCINATION 18 0.0002
834 INJECTION SITE BRUISING 19 0.0002
835 CARDIOVASCULAR DISORDER 6 0.0002
836 POOR QUALITY SLEEP 5 0.0002
837 PRURITUS GENERALISED 5 0.0002
838 FAECES DISCOLOURED 5 0.0002
839 BLOOD CREATININE INCREASED 15 0.0002
840 NERVOUSNESS 12 0.0002
841 PRODUCT DISPENSING ERROR 5 0.0002
842 BLOOD GLUCOSE DECREASED 11 0.0002
843 CONFUSIONAL STATE 37 0.0002
844 DISEASE PROGRESSION 27 0.0002
845 HYPERKALAEMIA 8 0.0002
846 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
847 HOSPITALISATION 35 0.0002
848 LYMPHOCYTE COUNT DECREASED 4 0.0002
849 FEMUR FRACTURE 7 0.0002
850 PRODUCT SUBSTITUTION ISSUE 13 0.0002
851 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
852 HEPATOTOXICITY 5 0.0002
853 ISCHAEMIC STROKE 4 0.0002
854 THROMBOSIS 18 0.0002
855 GLOSSODYNIA 5 0.0002
856 DEVICE ISSUE 20 0.0002
857 SNEEZING 5 0.0002
858 TREMOR 37 0.0002
859 THROAT IRRITATION 10 0.0002
860 DISTURBANCE IN ATTENTION 12 0.0002
861 CHROMATURIA 5 0.0002
862 DRUG EFFECT INCOMPLETE 8 0.0002
863 METABOLIC ACIDOSIS 7 0.0002
864 LOSS OF CONSCIOUSNESS 28 0.0002
865 ABNORMAL DREAMS 6 0.0002
866 DYSGEUSIA 16 0.0002
867 BACTERIAL INFECTION 4 0.0002
868 TACHYCARDIA 19 0.0002
869 OSTEONECROSIS 7 0.0002
870 HEPATIC CIRRHOSIS 4 0.0002
871 INJECTION SITE HAEMORRHAGE 17 0.0002
872 DYSARTHRIA 8 0.0002
873 DRUG DOSE OMISSION 35 0.0002
874 HYPOCALCAEMIA 4 0.0002
875 EXPIRED PRODUCT ADMINISTERED 7 0.0002
876 MUSCULOSKELETAL PAIN 11 0.0002
877 LETHARGY 12 0.0002
878 DRUG INTERACTION 33 0.0002
879 SEPTIC SHOCK 9 0.0002
880 LIVER FUNCTION TEST ABNORMAL 6 0.0002
881 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
882 LIVER INJURY 5 0.0002
883 LIVER DISORDER 9 0.0002
884 NIGHTMARE 7 0.0002
885 OSTEONECROSIS OF JAW 5 0.0002
886 DELIRIUM 7 0.0002
887 PNEUMONIA ASPIRATION 5 0.0002
888 PRODUCT QUALITY ISSUE 27 0.0002
889 GASTRIC CANCER 5 0.0002
890 FEEDING DISORDER 4 0.0002
891 INCORRECT DOSE ADMINISTERED 45 0.0002
892 DYSKINESIA 8 0.0002
893 PANCYTOPENIA 11 0.0002
894 BLINDNESS 8 0.0002
895 BODY TEMPERATURE INCREASED 4 0.0002
896 FEBRILE NEUTROPENIA 13 0.0002
897 DRUG RESISTANCE 5 0.0002
898 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
899 HAEMATOMA 5 0.0002
900 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
901 HYPERGLYCAEMIA 7 0.0002
902 DRUG-INDUCED LIVER INJURY 6 0.0002
903 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
904 HALLUCINATION, VISUAL 4 0.0002
905 PANCREATITIS 10 0.0002
906 BRADYCARDIA 10 0.0002
907 RENAL FAILURE ACUTE 8 0.0002
908 NO ADVERSE EVENT 34 0.0002
909 IMPAIRED WORK ABILITY 4 0.0002
910 HIP FRACTURE 6 0.0002
911 DRUG INTOLERANCE 18 0.0002
912 THROAT TIGHTNESS 5 0.0002
913 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
914 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
915 IRRITABILITY 11 0.0002
916 SEIZURE 21 0.0002
917 VISUAL ACUITY REDUCED 6 0.0002
918 LEUKOPENIA 9 0.0002
919 URINARY RETENTION 6 0.0002
920 NEOPLASM MALIGNANT 12 0.0002
921 COLITIS ULCERATIVE 8 0.0002
922 PANCREATITIS ACUTE 4 0.0002
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
924 SUICIDAL IDEATION 16 0.0002
925 ADVERSE EVENT 16 0.0002
926 NEEDLE ISSUE 5 0.0002
927 BREAST CANCER 16 0.0002
928 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
929 LUNG NEOPLASM MALIGNANT 7 0.0002
930 CARDIAC ARREST 14 0.0002
931 RHABDOMYOLYSIS 7 0.0002
932 MULTIPLE SCLEROSIS 8 0.0002
933 BLOOD PRESSURE FLUCTUATION 4 0.0002
934 APHASIA 5 0.0002
935 CEREBROVASCULAR ACCIDENT 28 0.0002
936 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
937 ANAPHYLACTIC REACTION 9 0.0002
938 ENCEPHALOPATHY 4 0.0002
939 ABASIA 4 0.0002
940 NERVOUS SYSTEM DISORDER 5 0.0002
941 HYPONATRAEMIA 9 0.0002
942 MOOD SWINGS 5 0.0002
943 ANAPHYLACTIC SHOCK 4 0.0002
944 UNRESPONSIVE TO STIMULI 4 0.0002
945 DEATH 132 0.0002
946 SEDATION 4 0.0002
947 ABNORMAL BEHAVIOUR 6 0.0002
948 HEART RATE INCREASED 15 0.0002
949 GAIT INABILITY 5 0.0001
950 CARDIAC FAILURE 12 0.0001
951 JAUNDICE 4 0.0001
952 DISEASE RECURRENCE 7 0.0001
953 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
954 RESPIRATORY ARREST 4 0.0001
955 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
956 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
957 AGGRESSION 7 0.0001
958 PANCREATIC CARCINOMA 4 0.0001
959 VAGINAL HAEMORRHAGE 6 0.0001
960 C-REACTIVE PROTEIN INCREASED 5 0.0001
961 UNDERDOSE 10 0.0001
962 AGITATION 10 0.0001
963 DRUG ADMINISTRATION ERROR 4 0.0001
964 PLASMA CELL MYELOMA 5 0.0001
965 ARRHYTHMIA 6 0.0001
966 NEUTROPENIA 17 0.0001
967 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
968 INFUSION RELATED REACTION 8 0.0001
969 ANGER 4 0.0001
970 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
971 SUICIDE ATTEMPT 7 0.0001
972 DEVICE DISLOCATION 5 0.0001
973 EXPOSURE DURING PREGNANCY 7 0.0001
974 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
975 HEPATIC FUNCTION ABNORMAL 4 0.0001
976 HYPOGLYCAEMIA 5 0.0001
977 PRODUCT STORAGE ERROR 9 0.0001
978 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
979 DISORIENTATION 4 0.0001
980 NEUTROPHIL COUNT DECREASED 4 0.0001
981 CARDIO-RESPIRATORY ARREST 4 0.0001
982 CONVULSION 5 0.0001
983 PROSTATE CANCER 7 0.0001
984 BLADDER CANCER 5 0.0001
985 DRUG WITHDRAWAL SYNDROME 7 0.0001
986 DEVICE MALFUNCTION 5 0.0001
987 DRUG DOSE OMISSION BY DEVICE 5 0.0001
988 OVERDOSE 13 0.0001
989 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
990 DRUG DEPENDENCE 9 0.0001
991 DRUG ABUSE 4 0.0000
992 TOXICITY TO VARIOUS AGENTS 5 0.0000